These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 14630760

  • 1. Celecoxib, rofecoxib, and acute temporary visual impairment.
    Coulter DM, Clark DW, Savage RL.
    BMJ; 2003 Nov 22; 327(7425):1214-5. PubMed ID: 14630760
    [No Abstract] [Full Text] [Related]

  • 2. Celecoxib- and rofecoxib-induced delirium.
    Macknight C, Rojas-Fernandez CH.
    J Neuropsychiatry Clin Neurosci; 2001 Nov 22; 13(2):305-6. PubMed ID: 11449042
    [No Abstract] [Full Text] [Related]

  • 3. Celecoxib and rofecoxib.
    Brinker AD, Bonnel RA, Feight AG, Nourjah P.
    J Am Dent Assoc; 2001 Nov 22; 132(11):1502, 1504. PubMed ID: 11806062
    [No Abstract] [Full Text] [Related]

  • 4. Blood pressure control and rates of edema following the administration of the cyclooxygenase-2 specific inhibitors celecoxib versus rofecoxib in patients with systemic hypertension and osteoarthritis.
    Weaver A, Alderman M, Sperling R.
    Am J Cardiol; 2003 May 15; 91(10):1291-2. PubMed ID: 12745131
    [No Abstract] [Full Text] [Related]

  • 5. Are selective COX 2 inhibitors superior to traditional NSAIDs? Rofecoxib did not provide unequivocal benefit over traditional NSAIDs.
    Budenholzer BR.
    BMJ; 2002 Jul 20; 325(7356):161; author reply 161. PubMed ID: 12130617
    [No Abstract] [Full Text] [Related]

  • 6. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs.
    Phelan KM, Mosholder AD, Lu S.
    J Clin Psychiatry; 2003 Nov 20; 64(11):1328-34. PubMed ID: 14658947
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Summaries for patients. Cyclooxygenase-2 inhibitors and heart attacks: varying effects?
    Ann Intern Med; 2005 Feb 01; 142(3):I21. PubMed ID: 15684199
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiovascular events and COX-2 inhibitors.
    Fleming M.
    JAMA; 2001 Dec 12; 286(22):2808; author reply 2811-2. PubMed ID: 11735742
    [No Abstract] [Full Text] [Related]

  • 11. A side effect of COX-2 inhibitors.
    Harv Health Lett; 2003 Apr 12; 28(6):7. PubMed ID: 12777233
    [No Abstract] [Full Text] [Related]

  • 12. Intolerance reactions due to the selective cyclooxygenase type II inhibitors rofecoxib and celecoxib. Results of oral provocation tests in patients with NSAID hypersensitivity.
    Kruse R, Ruzicka T, Grewe M.
    Acta Derm Venereol; 2003 Apr 12; 83(3):183-5. PubMed ID: 12816152
    [Abstract] [Full Text] [Related]

  • 13. Interaction of rofecoxib and celecoxib with warfarin.
    Schaefer MG, Plowman BK, Morreale AP, Egan M.
    Am J Health Syst Pharm; 2003 Jul 01; 60(13):1319-23. PubMed ID: 12901032
    [Abstract] [Full Text] [Related]

  • 14. [Pseudoporphyria and coxib].
    Schmutz JL, Barbaud A, Trechot P.
    Ann Dermatol Venereol; 2006 Feb 01; 133(2):213. PubMed ID: 16508618
    [No Abstract] [Full Text] [Related]

  • 15. Disturbance of vision by COX-2 inhibitors.
    Coulter DM, Clark DW.
    Expert Opin Drug Saf; 2004 Nov 01; 3(6):607-14. PubMed ID: 15500419
    [Abstract] [Full Text] [Related]

  • 16. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov 01; 38(11):81-6. PubMed ID: 11138599
    [Abstract] [Full Text] [Related]

  • 17. [Vision impairment by COX-2 inhibitor and the sequelae of voluntary Vioxx recall].
    Meyer CH.
    Klin Monbl Augenheilkd; 2005 Jan 01; 222(1):62-3. PubMed ID: 15678404
    [No Abstract] [Full Text] [Related]

  • 18. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs.
    Perazella MA, Tray K.
    Am J Med; 2001 Jul 01; 111(1):64-7. PubMed ID: 11448662
    [No Abstract] [Full Text] [Related]

  • 19. Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction.
    Kimmel SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL.
    Ann Intern Med; 2005 Feb 01; 142(3):157-64. PubMed ID: 15684203
    [Abstract] [Full Text] [Related]

  • 20. Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs.
    Quiralte J, Delgado J, Sáenz de San Pedro B, López-Pascual E, Nieto MA, Ortega N, Florido JF, Conde J.
    Ann Allergy Asthma Immunol; 2004 Oct 01; 93(4):360-4. PubMed ID: 15521372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.